Weekly Analysts’ Ratings Updates for Chemours (CC)

Several brokerages have updated their recommendations and price targets on shares of Chemours (NYSE: CC) in the last few weeks:

  • 5/6/2026 – Chemours was given a new $30.00 price target by Mizuho.
  • 4/28/2026 – Chemours had its price target raised by Truist Financial Corporation from $27.00 to $30.00. They now have a “buy” rating on the stock.
  • 4/24/2026 – Chemours was upgraded by Zacks Research from “strong sell” to “hold”.
  • 4/20/2026 – Chemours had its “sell (d)” rating reaffirmed by Weiss Ratings.
  • 4/10/2026 – Chemours was given a new $26.00 price target by Royal Bank Of Canada. They now have an “outperform” rating on the stock.
  • 4/9/2026 – Chemours had its price target raised by UBS Group AG from $23.00 to $29.00. They now have a “buy” rating on the stock.
  • 4/9/2026 – Chemours had its price target raised by Truist Financial Corporation from $21.00 to $27.00. They now have a “buy” rating on the stock.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Sunday, May 17th will be paid a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date is Friday, May 15th. Chemours’s payout ratio is presently -14.11%.

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.

See Also

Receive News & Ratings for The Chemours Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Chemours Company and related companies with MarketBeat.com's FREE daily email newsletter.